Wilco Groenhuysen
In the newly created position, he will take the helm for the firm’s global finance functions and join the executive management team in charge of the worldwide launch of Novocure's Tumor Treating Fields (TTF) cancer therapy devices.
Prior to joining the team, Groenhuysen was executive VP and CFO of Cephalon.
Of his new appointment, he said: “We have the opportunity to transform cancer care for patients around the world.”